MannKind (MNKD) moved up sharply today due to an exclusive agreement it signed with United Therapeutics. In the deal, MNKD allows United to be responsible for global development, regulatory and commercial activities for the development and commercialization of a product being developed by MNKD to treat pulmonary arterial hypertension. Here’s a recap of the trade […]
Read Article
Crude prices rose sharply to start September, up 2.1% to $71.29/bbl, fueled by the evacuation of two Anadarko (NYSE:APC) platforms in the Gulf of Mexico ahead of the approach of Hurricane Gordon, while ExxonMobil (NYSE:XOM) warned of a supply crunch in Nigeria (see both below). In addition, with “ship-tracking data now pointing at a reduction in Iranian exports, […]
Read Article
If you feel you are too heavy on the buy side in your portfolio, here is a stock that you could consider to short. It could be a hedge play or a short for those that are dying to sell this up-trending market. Tune in to see why $EW is a candidate to short and […]
Read Article
